Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,258 signal articles · 52 in last 24h · 115,243 total before filter · latest 1h ago
52last 24h
1809last 7d
299● bullish (7d)
171● bearish (7d)
205publishers
AllMacro322Earnings856M&A105Regulatory25Product16Analyst25
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?
Insider Monkey5d agoneutral
Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?

Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo authorization for its OTTAVA robotic surgical system. The authorization represents an important milestone for J&J’s MedTech ambitions, but the company is entering a market in which Intuitive Surgical (NASDAQ:ISRG) already has an extensive installed base, established surgeon […]

Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits
Simply Wall St.8d agobearish
Johnson & Johnson (JNJ) Reaches $5.5 Billion Talc Settlement To Close Years Of Lawsuits

Johnson & Johnson (NYSE: JNJ) agreed to a US$5.5b settlement to resolve tens of thousands of talc baby powder lawsuits. The deal ends decades of litigation over alleged health risks tied to the company’s talc-based products. The settlement follows years of high profile trials and failed bankruptcy attempts related to the talc claims. This resolution removes a long running legal overhang and brings more clarity for Johnson & Johnson investors. Consider broadening your research to other large...

What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?
Simply Wall St.8d agobearish
What Do Boston Scientific (BSX) Recalls Mean For Device Safety And Clinical Use?

Boston Scientific (NYSE: BSX) has initiated multiple product recalls covering cardiac ablation generators and vascular access sheaths due to labeling discrepancies and air embolism risks. The recalls affect a broad mix of devices used in cardiac and vascular procedures across several international markets. Regulators and hospitals are assessing the implications for device safety protocols, clinical workflows, and future use of the impacted products. Product safety questions can prompt...

Apple (AAPL) Seeks Injunction In AI Trade Secret Lawsuit
Simply Wall St.8d agobearish
Apple (AAPL) Seeks Injunction In AI Trade Secret Lawsuit

Apple (NasdaqGS:AAPL) has filed a lawsuit against OpenAI alleging misappropriation of confidential AI and hardware technology trade secrets. The complaint seeks a preliminary injunction that Apple says is needed to prevent irreparable harm to its core AI and device development work. The case could bring internal details of Apple's AI research, product security practices, and development processes into public view. Legal and competitive risks around AI intellectual property are back in focus...

Rackspace (RXT) Stock Still Looks Undervalued After Fraud Lawsuit News
Simply Wall St.8d agobearish
Rackspace (RXT) Stock Still Looks Undervalued After Fraud Lawsuit News

Rackspace Technology stock has delivered a very strong run year to date, yet its valuation checks still point to shares screening on the cheap side rather than fully pricing in that move. Year to date the share price is up 394.7%, which puts a lot more weight on whether current expectations for the business can hold. Investor focus is split between the potential upside from Rackspace Technology’s push into enterprise and sovereign AI infrastructure and the valuation risk tied to multiple...

Alibaba Group Holding (BABA) Faces A Lawsuit, Is The Stock Still Cheap?
Simply Wall St.8d agobearish
Alibaba Group Holding (BABA) Faces A Lawsuit, Is The Stock Still Cheap?

Alibaba Group Holding (NYSE:BABA) is back in the spotlight after Rosen Law Firm filed a class action lawsuit covering investors who bought the stock between June 26, 2025 and June 24, 2026. See our latest analysis for Alibaba Group Holding. Recent AI announcements, including the Qwen3.8 Max model and reports of potential automotive use cases, have helped Alibaba Group Holding’s 30 day share price return reach 29.21%. However, the year to date share price return remains down 18.58% and the 5...

Is Bloom Energy (BE) Undervalued Following The Lawsuit And Short Seller Report?
Simply Wall St.9d agobearish
Is Bloom Energy (BE) Undervalued Following The Lawsuit And Short Seller Report?

Bloom Energy (BE) is back in focus after a class action lawsuit was filed on July 31, 2026, following a short seller report on its scandium sourcing and a same day stock price decline. See our latest analysis for Bloom Energy. Recent events around Bloom Energy have played out against a backdrop of sharp share price swings, with the stock posting a 7 day share price return of 43.10% but a 30 day share price return down 20.58%. Despite this volatility, the year to date share price return of...

FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review
The Wall Street Journal9d agoneutral
FDA Approves First mRNA Flu Vaccine in Win for Moderna After Arduous Review

The Food and Drug Administration approved Moderna’s mRNA-based flu vaccine for adults ages 50 and older, clearing the first shot of its kind after a review process that nearly collapsed in February. The vaccine, called mFlusiva, uses the same mRNA technology as Moderna’s Covid-19 shots. It could reach pharmacies in time for the coming flu season, which typically starts in the fall.

Lululemon (LULU) Faces California Lawsuit Over Alleged Misleading Discount Prices
Simply Wall St.10d agobearish
Lululemon (LULU) Faces California Lawsuit Over Alleged Misleading Discount Prices

Lululemon athletica (NasdaqGS:LULU) is facing a consumer lawsuit in California that challenges its use of reference prices on discounted items. The complaint alleges that Lululemon used former prices that did not reflect actual recent selling prices, creating the appearance of larger discounts. The case adds to broader legal scrutiny of how major retailers communicate pricing and promotions to shoppers. Lululemon athletica has built its brand around premium athletic and leisure apparel,...

Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?
Simply Wall St.10d agobearish
Philip Morris International (PM) Faces Brazil Lawsuit Pressure, Is The Upside Already Priced In?

Philip Morris International (NYSE:PM) is back in focus after Brazil’s landmark public health lawsuit moved a step closer to a liability ruling, putting long running legal risks alongside fresh investment and earnings data. See our latest analysis for Philip Morris International. The share price of Philip Morris International has pulled back in the past week with a 7 day share price return of 6.6% in the red, even after a 90 day share price return of 9.6% and a 1 year total shareholder return...

Alphabet (GOOGL) Could Be 14% Undervalued On Ad Tech Lawsuit Scrutiny
Simply Wall St.11d agobearish
Alphabet (GOOGL) Could Be 14% Undervalued On Ad Tech Lawsuit Scrutiny

Alphabet (GOOGL) is back in the legal spotlight after Teads Holding Co. filed a lawsuit in New York accusing Google of exclusionary ad tech practices that restricted competition and revenue opportunities for independent advertising platforms. See our latest analysis for Alphabet. Alphabet’s share price has moved sharply in recent sessions, with a 1-day share price return of 4.88% and a 7-day share price return of 11.93% after recent earnings, AI investment updates, and renewed legal scrutiny...

Is Amazon.com (AMZN) A Bargain Following Its Latest Lawsuit And AI Fueled Rally?
Simply Wall St.11d agoneutral
Is Amazon.com (AMZN) A Bargain Following Its Latest Lawsuit And AI Fueled Rally?

Amazon.com (AMZN) stock is in focus after a consumer lawsuit filed on July 31, 2026, alleged the retailer sold Orgain protein powder containing harmful levels of heavy metals and misrepresented the products’ safety and quality attributes. See our latest analysis for Amazon.com. After the latest lawsuit headlines, Amazon.com’s recent share price moves still reflect strong momentum, with a 7 day share price return of 23.03% and a 1 year total shareholder return of 32.87%, which points to...

Alphabet (GOOGL) Faces Wrongful Death Lawsuit Over YouTube Claims About Targeting Minors
Simply Wall St.12d agobearish
Alphabet (GOOGL) Faces Wrongful Death Lawsuit Over YouTube Claims About Targeting Minors

A new wrongful death lawsuit has been filed against several tech companies, including Alphabet's YouTube. The complaint alleges that social media platforms knowingly targeted minors and concealed risks linked to child deaths. The case focuses on internal company behavior and platform oversight rather than typical shareholder or privacy issues. Alphabet, which trades on the NasdaqGS under the ticker NasdaqGS:GOOGL, is under fresh scrutiny as this lawsuit raises questions about YouTube's...

Uber (UBER) Faces Wrongful Death Lawsuit Over Fatal Uber Eats Delivery
Simply Wall St.12d agobearish
Uber (UBER) Faces Wrongful Death Lawsuit Over Fatal Uber Eats Delivery

A wrongful death lawsuit has been filed against Uber Technologies, Inc. (NYSE:UBER) and a contracted driver following a fatal incident linked to an Uber Eats delivery. The suit alleges negligence, gross negligence, and wrongful death in connection with the delivery trip. The case raises fresh questions about Uber's oversight of gig workers and its responsibility for incidents that occur during app based services. Uber Technologies runs ride hailing, food delivery, and other app based...

Altria Group (MO) Faces Investigation Over On! PLUS FDA Disclosure Claims
Simply Wall St.13d agobearish
Altria Group (MO) Faces Investigation Over On! PLUS FDA Disclosure Claims

Levi & Korsinsky has opened an investigation into Altria Group regarding disclosures tied to the FDA regulatory status of its on! PLUS nicotine pouch product. The review focuses on whether Altria accurately described near term FDA authorization prospects for on! PLUS in its public statements. This action introduces an additional legal and regulatory consideration for investors following NYSE:MO. Altria Group, trading under NYSE:MO, now faces questions around its communication practices at a...